1. Optimizing therapeutic targets for breast cancer using boolean network models
   Domenico Sgariglia et al, 2024, Computational Biology and Chemistry CrossRef
2. Hypoxia-Inducible Factor 1α and Its Role in Lung Injury: Adaptive or Maladaptive
   Madathilparambil V. Suresh et al, 2023, Inflammation CrossRef
3. Oxygen-Carbon Nanotubes as a Chemotherapy Sensitizer for Paclitaxel in Breast Cancer Treatment
   Yongkun Wang et al, 2014, PLoS ONE CrossRef
4. Relative refractoriness of breast cancer cells to tumour necrosis factor‐α induced necroptosis
   Banita Thakur et al, 2022, Clinical and Experimental Pharmacology and Physiology CrossRef
5. Synthesis and evaluation of biarylquinoline derivatives as novel HIF-1α inhibitors
   Yu-Chieh Wu et al, 2022, Bioorganic Chemistry CrossRef
6. The Effect of the Classical TSPO Ligand PK 11195 on In Vitro Cobalt Chloride Model of Hypoxia-like Condition in Lung and Brain Cell Lines
   Rula Amara et al, 2022, Biomolecules CrossRef
7. A New Classification Method of Metastatic Cancers Using a 1H-NMR-Based Approach: A Study Case of Melanoma, Breast, and Prostate Cancer Cell Lines
   null Schepkens et al, 2019, Metabolites CrossRef
8. Effect of aspirin on the TNF-α-mediated cell survival and death pathways in breast cancer
   Banita Thakur et al, 2023, Journal of Basic and Clinical Physiology and Pharmacology CrossRef
9. Metabolic profiling of breast cancer: Differences in central metabolism between subtypes of breast cancer cell lines
   Lucas Willmann et al, 2015, Journal of Chromatography B CrossRef
10. The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1α and VEGF
    Emine Şalva et al, 2015, International Journal of Pharmaceutics CrossRef
11. MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition
    Ning Liu et al, 2016, Scientific Reports CrossRef
12. Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition
    Supawan Jampasri et al, 2022, Molecules CrossRef
13. HIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets
    Tariq Shah et al, 2015, Oncotarget CrossRef
14. An overview of the effective combination therapies for the treatment of breast cancer
    Cristina Núñez et al, 2016, Biomaterials CrossRef
15. Intrinsic Disorder of the BAF Complex: Roles in Chromatin Remodeling and Disease Development
    null El Hadidy et al, 2019, International Journal of Molecular Sciences CrossRef
16. HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer
    Sylvia Mahara et al, 2016, Proceedings of the National Academy of Sciences CrossRef
17. HIF-1α acts as a molecular target for simvastatin cytotoxicity in B16.F10 melanoma cells cultured under chemically induced hypoxia
    Emilia Licarete et al, 2017, Oncology Letters CrossRef
18. Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer
    Wenbing Dai et al, 2014, Biomaterials CrossRef